# Crossover Post-herpetic Neuralgia (PHN)

> **NCT01305538** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 100 (actual)

## Conditions studied

- Post-Herpetic Neuralgia (PHN)

## Interventions

- **DRUG:** BMS-954561
- **DRUG:** BMS-954561
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01305538
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305538, "Crossover Post-herpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01305538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*